Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
46.00    0.00 (0.00%)
Bid:
45.00
Ask:
47.00
Spread: 2.00 (4.444%)
Market Cap: £208.13m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Update on the Offer for Subscription

6 Mar 2020 14:57

RNS Number : 3280F
Baronsmead Venture Trust PLC
06 March 2020
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

Baronsmead Venture Trust plc

6 March 2020

Update on the Offer for Subscription

The Board of Baronsmead Venture Trust plc (the "Company") announced on 4 October 2019 that it had published a Prospectus in conjunction with Baronsmead Second Venture Trust plc in relation to an offer for subscription to each raise up to £20 million (before costs) with an over-allotment facility to each raise up to a further £5 million (the "Offer").

On 27 February 2020 the Company carried out a third allotment of shares under the Offer, issuing 6,262,000 new ordinary shares of 10 pence each in the Company ("New Shares"). Subsequently, at the annual general meeting of the Company held on 26 February 2020, shareholders approved the payment of a final dividend of 3.5 pence per share (the "Final Dividend"). However, the net asset value as at 31 January 2020 did not take account of the Final Dividend and accordingly the net asset value used to calculate the issue price which the New Shares were issued at was overstated by the amount of the Final Dividend.

On the basis of the adjusted net asset value the Company has issued an additional 281,420 New Shares resulting in 6,543,420 New Shares being issued in the third allotment under the Offer at an issue price of 80.10 pence.

Applications have been made for the additional New Shares to be issued pursuant to the Offer to be admitted to the Official List (with a Premium Listing) and to the London Stock Exchange for the New Shares to be admitted to trading on the Main Market. It is expected that Admission will occur and dealing will commence in the additional New Shares to be issued pursuant to the Offer at 8.00 a.m. on 11 March 2020.

Share certificates and tax certificates in respect of the original issue of New Shares have not yet been issued. It is expected that share certificates and tax certificates showing the aggregate number of New Shares issued will be sent to the relevant Shareholders within 10 business days of the date of the allotment of the additional New Shares.

Total voting rights

Each Ordinary Share has one voting right. Following the issue of additional New Shares pursuant to the Offer, the Company will have 249,138,038 Ordinary Shares in issue (of which 20,731,897 Ordinary Shares are held in treasury). The total number of voting rights in the Company will therefore be 228,406,141 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Further information

For further information please contact.

Baronsmead VCT Investor Relations

020 3875 9862

baronsmeadvcts@greshamhouse.com

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

The issue and the distribution of this announcement and the Prospectus in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to in this announcement and the Prospectus comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEFLFESVEIRIII
Date   Source Headline
4th Oct 20175:03 pmRNSPublication of a Prospectus - Replacement
4th Oct 20174:30 pmRNSPublication of a Prospectus
2nd Oct 20177:00 amRNSTotal Voting Rights
27th Sep 20175:32 pmRNSTransaction in Own Shares
25th Sep 20174:30 pmRNSUpdate on Fundraising
20th Sep 20175:35 pmRNSCancellation of Share Premium Account
6th Sep 20172:30 pmRNSNet Asset Value(s)
4th Aug 20174:00 pmRNSNet Asset Value(s)
2nd Aug 20175:00 pmRNSIntention to Fundraise
13th Jul 201712:00 pmRNSNet Asset Value(s)
3rd Jul 201712:00 pmRNSTotal Voting Rights
29th Jun 20175:22 pmRNSTransaction in Own Shares
20th Jun 20177:00 amRNSDirector/PDMR Shareholding
6th Jun 20174:00 pmRNSNet Asset Value(s)
1st Jun 201711:00 amRNSTotal Voting Rights
24th May 20175:00 pmRNSTransaction in Own Shares
24th May 20177:00 amRNSHalf-year Report
5th May 20174:00 pmRNSNet Asset Value(s)
18th Apr 20173:30 pmRNSNet Asset Value(s)
3rd Apr 20174:22 pmRNSDirector/PDMR Shareholding
3rd Apr 201710:47 amRNSTotal Voting Rights
28th Mar 20174:50 pmRNSTransaction in Own Shares
6th Mar 201711:00 amRNSNet Asset Value(s)
2nd Mar 20177:00 amRNSDividend Declaration
14th Feb 20171:21 pmRNSResult of AGM
6th Feb 201712:00 pmRNSNet Asset Value(s)
19th Jan 201710:00 amRNSNet Asset Value(s)
3rd Jan 20171:55 pmRNSTotal Voting Rights
19th Dec 20163:10 pmRNSDirector/PDMR Shareholding
8th Dec 20164:27 pmRNSTransaction in Own Shares
6th Dec 20164:00 pmRNSNet Asset Value(s)
28th Nov 20161:00 pmRNSNet Asset Value(s)
17th Nov 20167:00 amRNSNet Asset Value(s)
17th Nov 20167:00 amRNSAnnual Financial Report
14th Oct 20163:00 pmRNSNet Asset Value(s)
11th Oct 201612:25 pmRNSDirector/PDMR Shareholding
3rd Oct 20162:29 pmRNSTotal Voting Rights
29th Sep 20165:01 pmRNSTransaction in Own Shares
26th Sep 20164:00 pmRNSNet Asset Value(s)
6th Sep 20163:30 pmRNSNet Asset Value(s)
24th Aug 20167:00 amRNSDividend Declaration
19th Aug 201610:30 amRNSNet Asset Value(s)
19th Aug 20167:00 amRNSNet Asset Value(s)
1st Jul 201610:11 amRNSTotal Voting Rights
29th Jun 20164:52 pmRNSTransaction in Own Shares
8th Jun 20165:42 pmRNSDirector/PDMR Shareholding
6th Jun 20164:28 pmRNSNet Asset Value(s)
1st Jun 20164:18 pmRNSTransaction in Own Shares
31st May 20166:08 pmRNSDirectorate Change
24th May 20165:08 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.